A major determinant of the immunogenicity of factor VIII in a murine model is independent of its procoagulant function

A main complication of treatment of patients with hemophilia A is the development of anti–factor VIII (fVIII) antibodies. The immunogenicity of fVIII potentially is a function of its procoagulant activity, which may result in danger signals that drive the immune response. Alternatively, intrinsic st...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Meeks, Shannon L., Cox, Courtney L., Healey, John F., Parker, Ernest T., Doshi, Bhavya S., Gangadharan, Bagirath, Barrow, Rachel T., Lollar, Pete
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Hematology 2012
Gaiak:
Thrombosis and Hemostasis
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3448263/
https://ncbi.nlm.nih.gov/pubmed/22855607
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2012-02-412361
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak